Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation

被引:349
|
作者
Kurki, S
Peltonen, K
Latonen, L
Kiviharju, TM
Ojala, PM
Meek, D
Laiho, M
机构
[1] Univ Helsinki, Biomedicum, Haartman Inst, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Biomedicum, Mol Canc Biol Res Program, FIN-00014 Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Diagnost Lab, FIN-00014 Helsinki, Finland
[4] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland
基金
芬兰科学院;
关键词
D O I
10.1016/S1535-6108(04)00110-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nucleophosmin (NPM, B23) is an abundant nucleolar phosphoprotein involved in ribosome biogenesis, and interacts with tumor suppressor proteins p53 and Rb. Here we show that NPM is a UV damage response protein that undergoes nucleoplasmic redistribution and regulates p53 and HDM2 levels and their interaction. By utilizing RNAi approaches and analyses of endogenous and ectopically expressed proteins, we demonstrate that NPM binds HDM2 and acts as a negative regulator of p53-HDM2 interaction. Viral stress, enforced by expression of Kaposi's sarcoma virus K cyclin, causes NPM redistribution, K cyclin-NPM association, and p53 stabilization by dissociation of HDM2-p53 complexes. The results demonstrate novel associations of HDM2 and K cyclin with NPM and implicate NPM as a crucial controller of p53 through inhibition of HDM2.
引用
收藏
页码:465 / 475
页数:11
相关论文
共 50 条
  • [11] Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26
    Zhang, Ying
    Wang, Jian
    Yuan, Yanzhi
    Zhang, Wanqiao
    Guan, Wei
    Wu, Zhihao
    Jin, Chaozhi
    Chen, Hui
    Zhang, Lingqiang
    Yang, Xiaoming
    He, Fuchu
    NUCLEIC ACIDS RESEARCH, 2010, 38 (19) : 6544 - 6554
  • [12] CARE binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway
    Kamrul, Hasan M.
    Wadhwa, Renu
    Kaul, Sunil C.
    BIOGERONTOLOGY: MECHANISMS AND INTERVENTIONS, 2007, 1100 : 312 - 315
  • [13] Inhibition of HDM2 and activation of p53 by ribosomal protein L23
    Jin, A
    Itahana, K
    O'Keefe, K
    Zhang, Y
    MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (17) : 7669 - 7680
  • [14] Human hdm2/p53 interaction antagonists
    Westwell, AD
    Langston, S
    DRUG DISCOVERY TODAY, 2001, 6 (02) : 102 - 103
  • [15] Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds
    Liu, Li-Juan
    He, Bingyong
    Miles, Jennifer A.
    Wang, Wanhe
    Mao, Zhifeng
    Che, Weng Ian
    Lu, Jin-Jian
    Chen, Xiu-Ping
    Wilson, Andrew J.
    Ma, Dik-Lung
    Leung, Chung-Hang
    ONCOTARGET, 2016, 7 (12) : 13965 - 13975
  • [16] Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction
    Peter M. Fischer
    International Journal of Peptide Research and Therapeutics, 2006, 12 : 3 - 19
  • [17] Activity-Directed Synthesis of Inhibitors of the p53/hDM2 Protein-Protein Interaction
    Green, Adam I.
    Hobor, Fruzsina
    Tinworth, Christopher P.
    Warriner, Stuart
    Wilson, Andrew J.
    Nelson, Adam
    CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (47) : 10682 - 10689
  • [18] HDM2 negatively affects the Chk2-mediated phosphorylation of p53
    Bjorling-Poulsen, M
    Meek, D
    Issinger, OG
    FEBS LETTERS, 2005, 579 (12): : 2604 - 2608
  • [19] Nucleophosmin, HDM2 and p53 - Players in UV damage incited nucleolar stress response
    Kurki, S
    Peltonen, K
    Laiho, M
    CELL CYCLE, 2004, 3 (08) : 976 - 979
  • [20] Coupling of the antennapedia third helix to a potent antagonist of the p53/hdm2 protein-protein interaction
    García-Echeverría, C
    Furet, P
    Chène, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (16) : 2161 - 2164